---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-000805"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T15:47:28.287963+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma regains Nasdaq minimum bid price compliance

## Summary
- Received Staff notice on Feb 9, 2023, confirming compliance with $1 bid price rule.
- Regained compliance removes immediate delisting risk from Nasdaq.
- Company's common stock (SBFM) and warrants (SBFMW) continue trading on Nasdaq.

## SEC filing metadata
- accession: 0001683168-23-000805
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/0001683168-23-000805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-000805
- JSON: https://secwatch.observer/filing/0001683168-23-000805.json
- Plain text: https://secwatch.observer/filing/0001683168-23-000805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.